Statin Use May be Regarded as one of the General Measures for Reducing the Risk of Venous Thromboembolism

Pavel      Poredoš; Debabrata      Mukherjee; Aleš      Blinc

doi:10.2174/157016112206241016115556

« Previous Next »

[1]
Tsiantoula P, Papaioannou V, Giannakopoulos NN, Papas TT. Statins, venous thromboembolism and cardiovascular events. Curr Vasc Pharmacol  2024; 22(6): 735-376.
 [http://dx.doi.org/10.2174/0115701611335138240731112405]

[2]
Poredoš P, Mukherjee D, Blinc A. Statins and Venous Thromboembolic Disease - Where are we Now? Curr Vasc Pharmacol Curr Vasc Pharmacol  2024; 22(4): 297-300.
 [http://dx.doi.org/10.2174/0115701611308323240229050237] [PMID:  38441024]

[3]
Rahimi K, Bhala N, Kamphuisen P, et al. Effect of statins on venous thromboembolic events: A meta-analysis of published and unpublished evidence from randomized controlled trials. PLoS Med  2012; 9(9): e1001310.
 [http://dx.doi.org/10.1371/journal.pmed.1001310]

[4]
Kunutsor SK, Seidu S, Khunti K. Statins and primary prevention of venous thromboembolism: a systematic review and meta-analysis. Lancet Haematol  2017; 4: e83-93.
 [http://dx.doi.org/10.1016/S2352-3026(16)30184-3]

[5]
Davis JW, Weller SC, Porterfield L, et al. Statin use and the risk of venous thromboembolism in women taking hormone therapy. JAMA Netw Open  2023; 6: e2348213.
 [http://dx.doi.org/10.1001/jamanetworkopen.2023.48213]

[6]
Ma XS, Sun J, Geng R, et al. Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study.  Nutr Metab Cardiovasc Dis  2023; 33: 1087-92.
 [http://dx.doi.org/10.1016/j.numecd.2023.02.023]

[7]
Mismetti P, Laporte S, Darmon JY, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general] surgery. Br J Surg  2001; 88: 913-30.
 [http://dx.doi.org/10.1046/j.0007-1323.2001.01800.x]

Rights & Permissions Print Cite

Article Metrics

6

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/157016112206241016115556	Print ISSN 1570-1611
Publisher Name Bentham Science Publisher	Online ISSN 1875-6212

Current Vascular Pharmacology

Statin Use May be Regarded as one of the General Measures for Reducing the Risk of Venous Thromboembolism

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Current Vascular Pharmacology

Statin Use May be Regarded as one of the General Measures for Reducing the Risk of Venous Thromboembolism

Call for Papers in Thematic Issues

TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE

Related Journals

Related Books